Structure via PubChem · Public domain (PubChem)
salinomycin
Sign in to saveSalinomycin is an antibacterial and coccidiostat ionophore therapeutic drug. It is widely researched for its anticancer stem cell properties.
Chemical data
- Formula
- C42H70O11
- Molecular weight
- 751 g/mol
- IUPAC name
- (2R)-2-[(5S,6R)-6-[(2S,3S,4S,6R)-6-[(3S,5R,7S,9S,10S,12R,15R)-3-[(2R,5R,6S)-5-ethyl-5-hydroxy-6-methyloxan-2-yl]-15-hydroxy-3,10,12-trimethyl-4,6,8-trioxadispiro[4.1.57.35]pentadec-13-en-9-yl]-3-hydroxy-4-methyl-5-oxooctan-2-yl]-5-methyloxan-2-yl]butanoic acid
via PubChem
Drug data · ChEMBL
- Max clinical phase
- Phase 2
- Molecule type
- Small molecule
via ChEMBL · EBI
Research
1,330 papers- Salinomycin as a potent anticancer stem cell agent: State of the art and future directions.Medicinal research reviews · 2022
- Salinomycin: A new paradigm in cancer therapy.Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine · 2017
- Doxycycline, salinomycin, monensin and ivermectin repositioned as cancer drugs.Bioorganic & medicinal chemistry letters · 2019
- Dichloroacetate and Salinomycin as Therapeutic Agents in Cancer.Medical sciences (Basel, Switzerland) · 2025
- Salinomycin, as an autophagy modulator-- a new avenue to anticancer: a review.Journal of experimental & clinical cancer research : CR · 2018
via PubMed
Wikidata facts
- Mass
- 750.49181306
Show 4 more facts
- chemical formula
- C₄₂H₇₀O₁₁
- isomeric SMILES
- O=C([C@H]([C@H]([C@@H]([C@]3([H])O[C@]([C@@H](CC)C(O)=O)([H])CC[C@@H]3C)C)O)C)[C@H](CC)[C@@]([C@@H](C)C[C@H]2C)([H])O[C@]12O[C@@]4(CC[C@]([C@]5([H])O[C@@H](C)[C@](CC)(O)CC5)(C)O4)[C@H](O)C=C1
- NCI Thesaurus ID
- C76430
- canonical SMILES
- O=C(O)C(CC)C1OC(C(C)CC1)C(C)C(O)C(C(=O)C(CC)C2OC3(OC4(OC(C)(CC4)C5OC(C)C(O)(CC)CC5)C(O)C=C3)C(C)CC2C)C
via Wikidata · CC0
~5 min read
Article
7 sectionsContents
- Antibacterial activity
- Cancer research
- Pre-clinical
- Use in agriculture
- Biosynthesis
- See also
- References
Salinomycin is an antibacterial and coccidiostat ionophore therapeutic drug. It is widely researched for its anticancer stem cell properties.
Salinomycin is also known to isomerise in solution. This unique property complicates its structural elucidation studies in areas such as analytical chemistry and pharmaceutical development. Mass spectrometry is the primary research technique in the analysis of polyether ionophores such as salinomycin. Different salinomycin isomers can generate unique sets of product ions in the mass spectrometer. A complete structural characterisation and fragmentation pathways for salinomycin and its isomers is important in understanding its fragmentation behaviour and provides firm ground for its future clinical drug discovery research.